Showing results (61-70 of 131) with videos related to
Sort By:
Pageof 14
International Journal of Clinical Oncology|September 11, 2020
Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickeningAkifumi Nakamura, Masaki Hashimoto, Hiroshi Kodama, et al.Journal of Thoracic Disease|December 7, 2020
Three tumor markers for improved efficacy in the management of patients with malignant pleural mesotheliomaAkifumi Nakamura, Teruhisa Takuwa, Masaki Hashimoto, et al.Journal of Surgical Case Reports|October 29, 2025
Salvage resection after immunotherapy for giant undifferentiated pleomorphic sarcoma of the chest wallAkifumi Nakamura, Ayumi Kuroda, Masaki Hashimoto, et al.The Annals of Thoracic Surgery|July 25, 2026
Efficacy of Perioperative Platinum-Pemetrexed Chemotherapy Combined with Pleurectomy/Decortication for Pleural MesotheliomaAkifumi Nakamura, Masaki Hashimoto, Nobuyuki Kondo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancerShinya Ishikawa, Kazumasa Takenaka, Kazuhiro Yanagihara, et al.Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|June 25, 2011
[Current status and future direction of Japan's clinical trial for malignant pleural mesothelioma]Seiki Hasegawa, Fumihiro Tanaka, Morihito Okada, et al.Annals of Surgical Oncology|October 30, 2020
Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural MesotheliomaAkifumi Nakamura, Nobuyuki Kondo, Toru Nakamichi, et al.Thoracic Cancer|November 20, 2021
Non-incisional pleurectomy/decortication for malignant mesothelioma after cardiac surgeryKentaro Miura, Kimihiro Shimizu, Seiki Hasegawa, et al.Nuclear Medicine Communications|June 10, 2020
Comparison of modified Response Evaluation Criteria in Solid Tumors, European Organization for Research and Treatment of Cancer criteria, and PET Response Criteria in Solid Tumors for evaluation of tumor response to chemotherapy and prognosis prediction in patients with unresectable malignant pleural mesotheliomaKazuhiro Kitajima, Mitsunari Maruyama, Toshiyuki Minami, et al.Oncotarget|June 17, 2021
Deep learning with deep convolutional neural network using FDG-PET/CT for malignant pleural mesothelioma diagnosisKazuhiro Kitajima, Hidetoshi Matsuo, Atsushi Kono, et al.Pageof 14